Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

NuScale Power Stock Gains Momentum with Major Nuclear Partnership

Robert Sasse by Robert Sasse
September 15, 2025
in Analysis, Energy & Oil, Mergers & Acquisitions
0
Nuscale Power Stock
0
SHARES
169
VIEWS
Share on FacebookShare on Twitter

NuScale Power shares demonstrated notable strength last week, posting gains exceeding 5%. This upward trajectory is largely attributed to the market’s continued positive reception of the company’s landmark 6-gigawatt collaborative agreement with ENTRA1 Energy and the Tennessee Valley Authority (TVA).

Strategic Partnership Fuels Market Confidence

The substantial partnership is centered on the deployment of up to 6 GW of NRC-certified small modular reactor (SMR) capacity throughout the TVA’s service territory. This initiative is designed to supply carbon-free baseload power to meet America’s escalating energy demands, specifically catering to high-consumption sectors such as artificial intelligence, hyperscale data centers, and semiconductor manufacturing.

Market experts have responded favorably to these developments. In early September, both Canaccord Genuity and Bank of America raised their price targets for NuScale Power. UBS followed by increasing its own target from $34 to $38 per share. The consensus average price objective now resides in a range between $36.20 and $38.33.

Should investors sell immediately? Or is it worth buying Nuscale Power?

A Distinct Competitive Edge

A key factor driving optimism is NuScale’s unique standing as the sole SMR technology provider with designs already certified by the Nuclear Regulatory Commission. This critical regulatory milestone significantly bolsters the technology’s credibility and readiness for deployment. The current surge in demand for dependable, clean energy sources positions the company at the forefront of a transforming energy sector.

Looking ahead, the focus turns to execution. CEO John Hopkins has outlined ambitious objectives, stating that NuScale aims to secure “firm contracts” with two or three major U.S. utility customers by the end of 2025. The momentum generated by the TVA alliance, coupled with expanding interest from multiple industries, provides a solid foundation for achieving this goal.

Closing the week at $36.34, NuScale’s stock price is now trading within the range of many analyst projections. The company’s upcoming quarterly results, scheduled for November 6th, will be a crucial indicator of its progress in transitioning from research and development to full-scale commercial implementation.

Ad

Nuscale Power Stock: Buy or Sell?! New Nuscale Power Analysis from February 7 delivers the answer:

The latest Nuscale Power figures speak for themselves: Urgent action needed for Nuscale Power investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nuscale Power: Buy or sell? Read more here...

Tags: Nuscale Power
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
Gartner Stock

Can Gartner's Massive Share Buyback Reverse Its Stock Decline?

Incyte Stock

Incyte Investors Await Pivotal FDA Ruling on Dermatology Drug

MP Materials Stock

MP Materials Navigates Strategic Gains Amid Financial Headwinds

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com